PMC:7299399 / 20800-21435
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T94 | 146-151 | Body_part | denotes | lungs | http://purl.org/sig/ont/fma/fma68877 |
T95 | 215-219 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
T96 | 530-537 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T27 | 215-219 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T75 | 34-44 | Disease | denotes | infections | http://purl.obolibrary.org/obo/MONDO_0005550 |
T76 | 188-207 | Disease | denotes | respiratory disease | http://purl.obolibrary.org/obo/MONDO_0005087 |
T77 | 513-521 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T78 | 539-542 | Disease | denotes | Ad5 | http://purl.obolibrary.org/obo/MONDO_0011194 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T210 | 107-112 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
T211 | 146-151 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lungs |
T212 | 215-219 | http://purl.obolibrary.org/obo/UBERON_0002048 | denotes | lung |
T213 | 215-219 | http://www.ebi.ac.uk/efo/EFO_0000934 | denotes | lung |
T214 | 247-254 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animals |
T215 | 269-270 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T216 | 426-427 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T217 | 568-574 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T133 | 530-537 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T134 | 586-588 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T91 | 0-635 | Sentence | denotes | The vaccine was unable to prevent infections, although it reduced the severity of the disease: no signs of virus replication were observed in the lungs, with significantly lower levels of respiratory disease and no lung damage compared to control animals, according to a recent article deposited in bioRxiv.69 Another adenoviral vector vaccine developed by CanSino Biological Inc. and Beijing Institute of Biotechnology using a genetically engineered replication-defective adenovirus type 5 vector to express the SARS-CoV-2 spike protein (Ad5-nCoV) is currently being tested in Phase I/II trials (NCT04398147, NCT04341389, NCT0431312). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
308 | 539-542 | Gene | denotes | Ad5 | Gene:8081 |
309 | 524-529 | Gene | denotes | spike | Gene:43740568 |
311 | 578-588 | Gene | denotes | Phase I/II | |
318 | 473-490 | Species | denotes | adenovirus type 5 | Tax:28285 |
319 | 513-523 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
320 | 543-547 | Species | denotes | nCoV | Tax:2697049 |
322 | 34-44 | Disease | denotes | infections | MESH:D007239 |
323 | 188-207 | Disease | denotes | respiratory disease | MESH:D012140 |